Market Scenario
The global medical bionic implant market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the medical bionic implant market is expected to register a CAGR of 7.0% during the forecast period of 2018–2023.
Bionic implants are artificially engineered devices that are implanted into a human to replace a natural organ. The main purpose of bionic implants is to provide life support to prevent imminent death while awaiting a transplant and improve a patient's ability to interact socially.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6051
It is observed that the increasing cases of organ failure have increased the demand for replaceable organs, which is propelling the medical bionic implant/artificial organs market to a great extent. According to the statistics suggested by the National Kidney Foundation, 2016 around 121,678 people were waiting for lifesaving organ transplants in the in the United States. It is also reported that in 2014, 17,107 kidney transplants took place in the U.S. The incidences of organ failure are found to be more common in the aging population, as it is more vulnerable towards health issues such as ophthalmic diseases, gastrointestinal problems, orthopedic diseases, cancer, and others.
Various other factors such as technological advancements, increasing accidents and injuries, improving regulatory framework, increasing government assistance, and increasing prevalence of eye diseases are continuously contributing to the growth of the global medical bionic implant/artificial organs market.
Despite these drivers, there are some issues associated with the medical bionic implant/artificial organs market. Lack of skilled professionals, the high cost of devices, fear of malfunction of devices, and poor healthcare system in low and middle-income countries may hamper the growth of the market to an extent.
Regional Market Summary
The Americas dominates the medical bionic implant/artificial organs market owing to the introduction of advanced medical bionic implants by major market players. On November 02, 2017, Second Sight Medical Products, Inc., a U.S. based company, received the U.S. FDA approval to initiate the Orion Cortical Visual Prosthesis System (Orion) feasibility clinical study. In 2013, the company won the FDA approval for the Argus II retinal prosthesis system.
Europe holds the second position in the medical bionic implant/artificial organs market. It is expected that the government support towards research and development expenditure and increasing cases of organ failure and related complications are likely to drive the European market.
Asia Pacific is the fastest growing medical bionic implant/artificial organs market owing to a huge patient pool, increasing demand for advanced treatments, and development in the healthcare technology. Healthcare expenditure is found to be improving in various Asia Pacific regions. According to the data suggested by Australian Institute of Health and Welfare during the year 2015 to 2016, the total health expenditure was USD 170.4 billion, i.e., 3.6% higher than the expenditure during 2014 to 2015.
The Middle East and Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.
Key Players
Some of key the players in the global medical bionic implant/artificial organs market are Aleva Neurotherapeutics SA (Switzerland), Biocontrol Medical (Israel), Biomet, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Ltd. (Australia), Cyberonics, Inc. (U.S.), Ekso Bionics (U.S.), LivaNova PLC (U.K), Medtronic, Inc. (U.S.), NeuroPace, Inc. (U.S.), Orthofix International N.V. (The Netherlands), Ossur (Iceland), Second Sight Medical Products, Inc. (U.S.), and St. Jude Medical, Inc. (U.S.).
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/medical-bionic-implant-artificial-organs-market-6051
Medical Bionic Implant/Artificial Organs Market OverviewA bionic implant is an artificially engineered device that is implanted to replace a natural organ in a human, with the purpose to provide life support while awaiting a transplant and improves a patient's ability to interact socially.According to the report published by Market Research Future (MRFR), the global medical bionic implant/artificial organs market is anticipated to grow exponentially and register a CAGR of 7.0% over the forecast period of 2018 to 2023.The growing cases of organ failure have improved the demand for replaceable organs, which contributes to the market growth of the medical bionic implant/artificial organs market to a great extent.
The prevalence of organ failure is found to be more common among the elderly consumers, as they are more vulnerable towards health issues such as gastrointestinal problems, ophthalmic diseases, cancer, orthopedic diseases, among others.
Other influential factors such as technological advancements, a growing number of accidents and injuries, improving the government regulatory framework and assistance, and the increasing prevalence of eye diseases are constantly contributing to create growth in the global medical bionic implant/artificial organs market.Despite these positive factors, issues connected with the medical bionic implant/artificial organs market are lack of skilled professionals, the high expenditure on devices, risk of malfunction of devices, and the comparatively poor healthcare system in low and middle-income countries may obstruct the growth of the market to an extent.Medical Bionic Implant/Artificial Organs Market Segmental AnalysisThe market for global medical bionic implant/artificial organs is segmented by technology, product, fixation, end-user, and region.Based on technology, the market is bifurcated as mechanical bionics and electronic bionics.Based on the product, the market is classified as vision bionics, orthopedic bionics, ear bionics, neural/brain bionics, heart bionics, and others.
Ear bionics are further segmented as Bone Anchored Hearing Aid (BAHA) and cochlear implant.
Orthopedic bionics is sub-segmented as an exoskeleton, bionic leg, bionic hand, bionic finger, and electrical bone growth stimulators.
The sub-segments of the bionic leg include bionic knee and bionic feet.
Global Cardiac Monitoring and Cardiac Rhythm Management Device Market, by Cardiac Device (Pacemaker and Others), by Cardiac Monitoring (Electrocardiogram), by CRM (Defibrillators and Others), by End-User (Hospitals and Others)–Global Forecast Till 2027Market HighlightsRising prevalence of cardiovascular diseases and the increasing number of unmet medical needs in undeveloped countries are leading to the growth of the cardiac monitoring and cardiac rhythm management device market.
Technical advancements in drug-eluting, MRI compatible pacemakers, and Holter monitors are some of the factors leading to the growth of this market.
The growth of the global cardiac monitoring device market is driven by the high prevalence of cardiovascular disorders worldwide.
However, factors such as stringent regulatory approval procedures, the high cost of cardiac devices, and lack of reimbursement policies in developing countries are hindering the growth of the market.Regional AnalysisThe market in the Americas is expected to dominate the global cardiac monitoring and cardiac rhythm management device market during the forecast period owing to the increasing prevalence of chronic kidney diseases along with the growing geriatric population and well-established healthcare sector in the region.
The European market is expected to be the second-largest due to government funding and support from the healthcare sector, coupled with increasing research and development.
Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to technological developments, an increasing number of advanced surgeries in emerging economies, and favorable government initiatives for healthcare facilities.
Market OverviewThe global position sensors market is anticipated to surpass a valuation of USD 6 billion, attaining a CAGR of 8% during the forecast period (2016-2022), Market Research Future (MRFR) reveals in a detailed report.
High adoption of position sensors in the aerospace and aviation industries are likely to fuel the market growth globally.Market Potential and PitfallsThe Position Sensor Industry is expected to experience a sturdy growth, mainly due to the surging adoption of latest technologies like integrated control system for consumer electronics.
The surging demand for plant automation, rising investments by manufacturers, and the rising adoption of sensors across industries are some of the crucial factors for the growth of the market.
Moreover, the growing adoption of wearable medical devices, coupled with the need for high-performance sensors are likely to propel the market growth across the globe.On the contrary, high cost and the need for multiple technology solutions are some of the major concerns likely to dampen the growth of the Position Sensor Industry in the foreseeable future.Get More Details of Report @ https://www.abnewswire.com/pressreleases/position-sensor-market-size-share-2019-global-analysis-by-trends-opportunities-key-players-sales-revenue-business-growth-competitive-landscape-and-regional-forecast-2022_433133.htmlKey PlayersPosition Sensor Market key players include- Honeywell International, Inc. (US), Ams AG (Germany), MTS Systems Corporation (US), Renishaw plc.
(UK), TE Connectivity Ltd. (Switzerland), Vishay Intertechnology, Inc. (US), Allegro MicroSystems, LLC (US), Panasonic Corporation (Japan), Infineon Technologies AG (Germany), STMicroelectronics N.V. (Switzerland), Qualcomm Technologies, Inc. (US), among others.Global Position Sensor Market - SegmentationThe position sensor market is segmented on the basis of contact type, output, type, and industries.By contact type, the position sensor market is segmented into contact and non-contact.
Among these, the automotive industry is likely to gain prominence due to the increased adoption of position sensors to gather critical information in the form of output signals to the engine control module, which is deployed in the vehicle to perform actions.Global Position Sensor Market - Regional AnalysisGeographically, the position sensor market spans across Europe, North America, Asia Pacific, and Rest of the World (RoW).Considering the global scenario, Europe acquired the largest market share due to the presence of strict law emissions in European countries.
The Benefit of Using an Automotive Braking System Includes:
The ABS technology helps in lowering the risk of wheels getting locked up and skidding in slippery conditions.
The automotive braking system market will witness a sharp rise owing to the rapidly growing demand for automobiles on account of an increase in disposable income.
Furthermore, the increasing number of road accidents has led the manufacturers to spend heavily in R to bring out state-of-art technology for advanced and safe braking systems which is also expected to anticipate the growth in the automotive braking system market size.
On the basis of System Type, the global automotive braking system market is segmented into Air/Pneumatic, Hydraulic, and Electromagnetic.
By geography, Automotive Braking System market is segmented as North America, South America, Europe, Middle East and Africa, and The Asia Pacific.
According to a new market research report "EMO Machine Market by Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), and Region - Analysis & Forecasts to 2021" published by MarketsandMarkets, The market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%.Browse 78 market data Tables and 31 Figures spread through 129 Pages and in-depth TOC on "Extracorporeal Membrane Oxygenation Machine Market"Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=255167654 The report analyzes and studies the major market drivers, restraints/challenges, and opportunities for the forecast period of 2016 to 2021.
However, complications associated with ECMO such as bleeding, infections, and technical failures; along with high cost and lack of skilled professionals is a challenge to the market.The global ECMO machine market is segmented on the basis of modality, applications, and regions.
The large share of this segment can be attributed to factors such as rising incidence of respiratory failure, lung cancer, and lung transplants, and increasing adoption of ECMO.On the basis of region, the global ECMO machine market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
In 2016, North America accounted for the largest share of the market, followed by Europe, Asia-Pacific, and the Rest of the World.
The Asia-Pacific market is projected to grow at the highest CAGR and serve as a revenue pocket for companies offering ECMO systems.Request For Sample Pages: http://www.marketsandmarkets.com/requestsample.asp?id=255167654 In 2015, the market was dominated by the Getinge Group (Sweden), Medtronic plc (Ireland), and LivaNova PLC (U.K.).
The other players in the Extracorporeal Membrane Oxygenation Machine Market are XENIOS AG (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.), ALung Technologies, Inc. (Germany), and EUROSETS S.r.l.
The global application delivery controller market is expected to reach USD 4.34 billion by 2024, according to a new report by Grand View Research, Inc.
This may be accredited to the increasing globalization and distributed enterprise architecture, which requires networks that can deliver their business-critical applications faster, thereby ensuring security.
The increase in the data center traffic and the growing ADC popularity, particularly in the consolidated data center segment, are expected to be the major factors spurring the ADC market growth over the forecast period.The increasing adoption of the BYOD phenomenon has led to the widespread usage of tablets and smartphones particularly in large organizations as it significantly increases the scope and span of enterprises.
This, in turn, has resulted in a rise in the ADC demand in order to balance and maintain the server load.
In addition, emerging technologies, such as software-defined storage (SDS) and software-defined networking (SDN), are also anticipated to spur the ADC market growth over the coming years.Further key findings from the report suggest:The virtual segment captured over 30% of the total revenue share in 2015 and is anticipated to exhibit growth exceeding 5.0% from 2016 to 2024.
This can be attributed to the improved IT agility, performance, and cost benefits offered by them over the hardware-based ADCs as well as the increasing cloud-based data center traffic.The small & medium enterprise (SME) segment is expected to gain prominence over the forecast period exceeding a compound annual growth rate of 5% from 2016 to 2024.
